$CRVO Income Statement | Understand Stock

$CRVO

$2.22 -$0.02 (0.89%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Grant revenue
Operating expenses:
Research and development
Intangible asset impairment charge
General and administrative
Depreciation
Total operating expenses
Loss from operations

Other income (expense):
Loss before income taxes
Income tax benefit
Other expense
Interest income
Interest expense
Total other income, net
Net loss
Deemed dividend arising from warrant exchange
Net loss applicable to common stockholders

Per share information:
Net loss per share of common stock, basic and diluted (in dollars per share)
Weighted average shares outstanding, basic and diluted (in dollars per share)
Weighted average shares outstanding, basic and diluted (in shares)

Net loss:
Net unrealized (loss) gain on marketable securities
Total comprehensive loss

Comments